(Q36914115)

17 August 2017

1 reference

title

Gender differences in dementia risk factors (English)

1 reference

17 August 2017

0 references

Nahid A Azad

1

1 reference

17 August 2017

Muneerah Al Bugami

series ordinal

2

1 reference

17 August 2017

Inge Loy-English

series ordinal

3

1 reference

17 August 2017

publication date

1 June 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

4

1 reference

17 August 2017

issue

2

1 reference

17 August 2017

page(s)

120-129

1 reference

Alzheimer's disease – a vascular dementia?

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Major risk factors as antecedents of fatal and nonfatal coronary heart disease events

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Diabetes in the elderly and in women: cardiovascular risks

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Risk factors for vascular dementia and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Sex differences in the clinical manifestations of Alzheimer disease pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Vascular factors in dementia: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Cardiovascular risk factors and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Age-specific incidence of Alzheimer's disease in a community population.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Alzheimer's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Sex differences in genetic risk for dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Education and APOE-e4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

The age-dependent relation of blood pressure to cognitive function and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Use of ramipril in preventing stroke: double blind randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Low blood pressure and the risk of dementia in very old individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

High total cholesterol levels in late life associated with a reduced risk of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Statins and cognitive function in the elderly: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Type 2 diabetes mellitus and cognition: an understudied issue in women's health

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Plasma C peptide level and cognitive function among older women without diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Homocysteine, estrogen and cognitive decline.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Homocysteine lowering and cognitive performance

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

An 18-year follow-up of overweight and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

A 24-year follow-up of body mass index and cerebral atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Light to moderate alcohol consumption is associated with better cognitive function among older male veterans receiving primary care

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Effects of moderate alcohol consumption on cognitive function in women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

The metabolic syndrome, inflammation, and risk of cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

The metabolic syndrome and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Effects of estrogen on congnition mood, and degenerative brain diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Effect of smoking on global cognitive function in nondemented elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

A 2-year follow-up study of cigarette smoking and risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study)

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study)

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980026-X

7 January 2021

10.1016/S1550-8579(07)80026-X

Identifiers

DOI

1 reference

17 August 2017

1 reference